Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. stocks fall sharply, amid weak global economic growth outlook

Published 04/05/2016, 04:35 PM
Updated 04/05/2016, 04:44 PM
The Dow, NASDAQ and S&P all fell broadly on Tuesday

Investing.com -- U.S. stocks fell broadly on Tuesday amid mounting fears of a weakening long-term economic outlook, as the major indices posted their worst two-day decline since early-February.

On Tuesday morning, Monetary Fund managing director Christine Lagarde said Tuesday that the global economic outlook has dimmed over the last six months, citing low inflation, weak growth opportunities, a lack of new jobs and high debt throughout the world. Separately, Federal Reserve Bank of Atlanta lowered its first quarter U.S. GDP growth estimate to 0.4%, from previous forecasts of 0.7% due primarily to soft vehicle sales in March, as well as declines in real consumer spending growth and real equipment investment growth. As a result, gold prices bounced from five-week lows in Tuesday's session while the Japanese Yen soared to one-year highs against the dollar, after investors sought shelter in the safe-haven assets.

The Dow Jones Industrial Average lost 133.68 or 0.75% to 17,603.32, closing near session-lows. It came as the Dow Jones Transportation Average fell 44.53 or 0.57% to 7,772.46, posting its ninth loss in the last 11 sessions. As a result, the Dow Transportation Index moved below its 200-day moving average for the first time in more than a week.

The NASDAQ Composite index, meanwhile, fell 47.87 or 0.98% to 4,843.93, while the S&P 500 Composite index dipped 20.96 or 1.01% to 2,045.17. On the S&P 500 all 10 sectors closed in the red, as stocks in the Utilities and Financials lagged. In total, four industries decreased by more than 1% on Tuesday. The S&P 500 briefly turned negative for the year during the session.

The top performer on the Dow was Pfizer Inc (NYSE:PFE), which added 0.66 or 2.15% to 31.38. Earlier, Reuters reported that the pharmaceutical giant may abandon a $160 billion merger with Allergan Plc (NYSE:AGN) after the U.S. Department of Treasury unveiled new rules on Monday aimed at curbing so-called tax inversion strategies. The new rule limits companies from engaging in the inversions if they have completed the deal over the last three years. In Pfizer (NYSE:PFE)'s case, the company reportedly planned to acquire Allergan (NYSE:AGN_pa) to establish the new company's headquarters in Dublin in an apparent move to reduce its U.S. tax burden.

"This is something that I’ve been pushing for a long time,” U.S. President Barack Obama said at a White House press conference on Tuesday. “When companies exploit loopholes like this, it makes it hard to invest in the kinds of things that are going to keep America’s economy going strong."

The worst performer was Cisco Systems Inc (NASDAQ:CSCO), which fell 0.56 or 1.99% to 27.58. Over the last 52 weeks, shares in the Silicon Valley networking equipment company are up fractionally by 1.34 points or 4.94%.

The biggest gainer on the NASDAQ was Tesla Motors Inc (NASDAQ:TSLA), which jumped 8.01 or 3.24% to 255.00, rallying sharply from a sell-off at the start of Tuesday's session. Tesla (NASDAQ:TSLA) shares popped after CEO Elon Musk blamed the company's failure to meet delivery targets in the first quarter with its top-of-the-line Model X vehicle on excessive hubris. The worst performer was Walker & Dunlop Inc (NYSE:WD), which fell 2.19 or 4.73% to 44.08.

"We put too many new features and technologies, too many great things all at once into a product," Musk said. "I do think there was some hubris there with the X. The net result, however, is that I think the Model X is an amazing car. Honestly, I think it's probably, I think it's the best car ever. I'm not sure anyone's going to make a car like this again."

The top performer on the S&P 500 was Newmont Mining Corporation (NYSE:NEM), which jumped 1.02 or 3.88% to 27.32, after gold halted a two-day losing streak with one of its best sessions in two weeks. Allergan closed as the worst performer after plunging 42.77 or 15.41% to 234.78.

On the New York Stock Exchange, declining issues outnumbered advancing ones by a 2,161-924 margin.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.